|
![]() |
AltaceThis page contains recent news articles, when available, and an overview of Altace but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Altace (when available) Ramipril is an angiotensin-converting enzyme (ACE) inhibitor similar to benazepril, fosinopril, and quinapril. An inactive prodrug, ramipril is converted to ramiprilat in the liver and is used to treat hypertension and heart failure, to reduce proteinuria and renal disease in patients with nephropathies, and to prevent stroke, myocardial infarction, and cardiac death in high-risk patients. Indicated for diuretics and digitalis in congestive heart failure as adjunctive therapy; prophylaxis in post MI. Mechanism Of Action: Ramiprilat, the active metabolite, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and an increase in plasma renin. Ramiprilat may also act on kininase II, an enzyme identical to ACE that degrades the vasodilator bradykinin. News Articles on Ramipril Patient in quandary whether to take hormone - Apr 18, 2009 Brand names of some of these drugs are Lotensin, Capoten, Vasotec, Monopril, Zestril, Univasc, Aceon, Accupril, Altace and Mavik. Cough is one of their side SouthCoastToday.com FDA Safety Changes: Luvox, Altace, Capozide, Monopril, Furadantin - Apr 8, 2009 Updated monographs include those for ramipril tablets and capsules (Altace, King Pharmaceuticals, Inc), captopril plus hydrochlorothiazide tablets (Capozide Medscape King Reports Fourth-Quarter Loss on Alpharma Purchase - Feb 26, 2009 Loss of patent protection for the blood-pressure pill Altace in late 2007 led King to shift its focus to neuroscience. The company formed two partnerships Bloomberg Ranbaxy gets US FDA nod for cardiovascular drugs - Mar 8, 2009 Ramipril, which can also be used for treating hypertension, is a bioequivalent to King Pharmaceuticals' Altace drug. The drug will be available in the Hindu Seeking Gain From Pain - Mar 3, 2009 First, patent expiration is crushing sales of King's former best-seller, the hypertension medication Altace, which has fallen from $646 million in 2007 Motley Fool Closing Bell - Mar 9, 2009 The US FDA determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference listed drug, Altace, Economic Times Janssen reps sue, alleging off-label Risperdal push; MannKind to ... - Mar 9, 2009 Release > Ranbaxy Laboratories got final FDA approval to sell its version of the King Pharmaceuticals cardiovascular drug Altace, the third approval for FiercePharma Novartis says strong dollar to weaken earnings; Biovail founder ... - Feb 26, 2009 ...largely due to the costs of acquiring rival Alpharma, but also because its Altace painkiller went off patent a year ago, causing sales to drop. FiercePharma Weis Markets Expands Low-Cost Prescription Plan - Feb 19, 2009 ...cholesterol, diabetes, infections and digestive ailments and the new generic drug Altace, which is used to treat high blood pressure and heart failure. PR Newswire (press release) King Pharmaceuticals muss Verlust ausweisen - Feb 26, 2009 Der Umsatzrückgang resultierte dabei vor allem aus zuletzt durch Konkurrenten vertriebene Generika-Versionen des Bluthochdruck-Medikaments Altace. Stock World King Pharmaceuticals Cuts 22% of Work Force - Feb 3, 2009 Since it lost a 2007 patent case involving its once top-selling Altace blood-pressure drug, King had shifted its focus onto other products, Wall Street Journal King Pharmaceuticals to lay off 70 at Bristol headquarters - Jan 30, 2009 King went through a similar downsizing in late 2007 — cutting 20 percent of its work force — when patents on its branded hypertension drug Altace led to its Kingsport Times News, King Pharmaceuticals plans to appeal loss of patent for Skelaxin - Jan 21, 2009 King, which employs about 500 people at its Bristol headquarters, survived an even bigger hit in September 2007 when its hypertension drug Altace went Kingsport Times News, Free ringtones tmobile - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace free ringtones tmobile generic ciales going the free ringtones tmobile at about Griggs County Courier, Doxycycline purchase - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace doxycycline purchase generic ciales going the doxycycline purchase at about Griggs County Courier, Buy androgel - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace buy androgel generic ciales going the buy androgel at about information. Griggs County Courier, Oxycodone pills - Jan 17, 2009 Know gardner p pediatric news views aciphex prescription phentermine altace oxycodone pills generic ciales going the oxycodone pills at about information. Griggs County Courier, Blood pressure medicine can cause hacking cough - Dec 22, 2008 Like other blood pressure drugs in this class (Accupril, Altace, benazepril, captopril, enalapril, ramipril and quinapril), lisinopril can cause a hacking Los Angeles Times, Medicine triggers hallucinations - Dec 22, 2008 Like other blood pressure drugs in this class (Accupril, Altace, benazepril, captopril, enalapril, ramipril and quinapril), lisinopril can cause cough as an Online Athens, Pain Therapeutics, King Fall as Drug to Thwart Abuse Is Delayed - Dec 11, 2008 King is under pressure from investors to introduce new drugs to replace revenue lost after its top-selling heart pill Altace went generic last year, Bloomberg December 2008 Mayo Clinic Health Letter Highlights: Colorectal ... - Dec 9, 2008 Altace (ramipril) for blood pressure and heart failure -- Ambien (zolpidem), a sleep aid -- Depakote (divalproex) for seizures, migraines and bipolar MarketWatch Sanofi-Aventis : un nouveau site à Floirac - Dec 15, 2008 Lantus, Copaxone, Aprovel, Avapro, Karvea, Tritace, Triatec, Delix, Altace, Allegra, Telfast, Amaryl, Amarel, Solosa, Xatral, Actonel, Dépakine. Échos Judiciaires Girondins, Pharma company poised to introduce new drug therapies - Sep 24, 2008 Driving the decline was a drop in sales of Altace of nearly $120 million. Although King announced a 20% reduction in the US salesforce following the adverse Stockhouse, Alpharma rejects King Pharma's $37 per share sweetened offer - Update - Sep 26, 2008 The proposal comes, as King Pharma is trying to reposition itself, as generic competition eroded sales of its best-selling blood pressure drug Altace. Trading Markets (press release), Weis Markets Completes Rollout of New 90-Day $9.99 Prescription ... - Oct 3, 2008 Weis Markets' 90-Day Prescription plan includes the new generic drug Altace, which is used to treat high blood pressure and heart failure. SYS-CON Media, [계ì˜?ê·œ 칼럼]걷기와 소ì‹?(å°?食)ì?˜ 기ì ? - Sep 28, 2008 ...그러다 7 ë…„ ì „ë¶€í„°ëŠ” 혈압까지 ì •ìƒ?치 보다 높다 하여 혈압 약(Altace 5mg)까지 매ì?¼ 한 알씩 추가로 복용 하게 ë?˜ì—ˆë‹¤. ê²°êµ ì•½ë¬¼ë§Œìœ¼ë¡œëŠ” 병ì?´ 났기는 커녕 세월ì?´ ìº?나다 ë°´ì¿ ë²„ 중앙ì?¼ë³´, There are a number of ways to fight restless legs Sep 13, 2008 ACE inhibitors include Vasotec, enalapril, captopril, Accupril, Altace and Mavik. If you are not sure about your medicine's safety with potassium,SouthCoastToday.com, King's Unstoppable Urge to Merge Sep 12, 2008 Hypertension treatment Altace has begun to face generic competition, and muscle relaxant Skelaxin will face generic competition sooner than expected.Motley Fool Market Likes Alpharma’s Rejection of King’s Rich Offer Aug 22, 2008 Last year, the company lost a patent lawsuit over its best-selling blood-pressure drug Altace. Earlier this month, the company said its second-quarter netWall Street Journal Blogs, Alpharma reports positive Embeda pain drug data Sep 9, 2008 King is eager to expand its presence in the pain drug market as sales of its blood pressure drug Altace reel from the impact of generic rivals.guardian.co.uk, Understanding hypertension Aug 18, 2008 We have medicines that inhibit the action of the kidney (such as Altace and Enalapril) and that block the places on the muscle where the hormone attachesStaten Island Advance - SILive.com, Throat and Tongue Swelling Can Be Lethal Aug 17, 2008 Lotensin, captopril, Vasotec, Lisinopril, Prinivil, Monopril, Zestril, Accupril, Altace and Mavik are examples. Other medicines involved in angioedema areRedOrbit, King Pharma offers $33 a share for Alpharma Aug 22, 2008 The proposal comes, as King Pharma is trying to reposition itself, as generic competition eroded sales of its best-selling blood pressure drug Altace.Trading Markets (press release), Pfizer may take over King Pharmaceuticals, analysts say - 06 Aug 2008 Pfizer may acquire King Pharmaceuticals, maker of the blood-pressure drug Altace, some analysts said. Representatives for both companies declined to comment SmartBrief, King Options Surge on Takeover Rumors - Aug 5, 2008 The firm makes money on its Altace blood-pressure pills, but recently shifted its focus to painkillers after its patent was taken away. LEAPSInvestor.com, Would Pfizer Buy King Pharmaceuticals? - Aug 5, 2008 King, which sells the Altace blood-pressure pill, shifted its focus to painkillers after a court ruling invalidated the drug’s patent last fall, Pharmalot, Lupin net up 101% at Rs 112 crore - Jul 22, 2008 King Pharmaceutical's branded product of Ramipril - Altace capsules, had an annual sales of $ 920 million in 2007. Lupin's advanced markets formulation Business Standard, Pharma Q1 show to stay robust - Jul 16, 2008 King Pharmaceutical's branded ramipril product, Altace, had sales of $920 million in 2007. Ranbaxy Laboratories, Glenmark, Zydus Cadila and Aurobindo are Business Standard, Gannon On Investing's July 2008 Blogger Roundtable - Jul 21, 2008 The stock got hammered, primarily because it lost patent protection for its largest drug (a heart drug called Altace) in 2007. King's strategy is to acquire Seeking Alpha, BUYINS.NET: (WYE) SqueezeTrigger Price is $44.892. There is ... - Jul 23, 2008 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release), Fundasalud registró 8.539 sucrenses con hipertensión - Jul 26, 2008 Los fármacos prescritos a los hipertensos son el Norvasc, Coraspirina, Lanicor y Altace, entre otros. Para recibir tratamiento contra la hipertensión, El Tiempo de Venezuela, FDA Denies King Pharma's Citizen Petition on Altace; Approves ... - Jun 26, 2008 Accordingly, the Petition seeks to confirm that ANDAs and 505(b)(2) applications that reference an Altace product must contain an appropriate patent Seeking Alpha, Lupin's BP drug finally gets US nod - Jun 11, 2008 Lupin will sell Altace in the US under the brand name Ramipril. It is currently sold in India under the name Ramistar. Lupin has spent about 6-7% of its Rs Sify, Lupin Asks Court for Ramipril Go-Ahead - Jun 16, 2008 The FDA tentatively approved Lupin’s ANDA for generic Altace (ramipril) capsules May 12, less than a week after the US Patent and Trademark Office assigned FDA news (subscription), Teva Introduces Ramipril Capsules - Jun 24, 2008 This product is AB rated and bioequivalent to Altace®* Capsules. Ramipril Capsules are available in 2.5 mg, 5 mg, and 10 mg strengths, in bottle sizes of PharmaLive.com (press release), Research and Markets: Dr. Reddy's Laboratories Generics Company ... - Jun 13, 2008 The company’s current best selling products include ramipril (Altace, King Pharmaceuticals), first introduced in non-US markets in 2003, and simvastatin, Business Wire (press release), Rebates to drug distributors questioned - Jun 2, 2008 I take a drug called Altace to lower my risk of cardiovascular troubles associated with diabetes. At the drugstore, my co-pay for Altace ran about $20 a Fresno Bee (subscription), Reduced breathing and heart rate on Aciphex - Jun 16, 2008 I had two stents installed in my heart last July, and started Altace, Plavix and Simvastatin to prevent further damage to my heart. Cyclingnews.com Popular Drugs, Side-Effects and Feeling Ill - Jul 1, 2008 Angiotensin-converting enzyme ( ACE ) inhibitors, such as enalapril (Vasotec), benazepril (Lotensin) and ramipril (Altace), as well as the Designer Drugs; Rocklin and Roseville Today, Lupin introduces Ramipril capsules - Jun 12, 2008 By Staff Writer Lupin's Ramipril capsules are the AB-rated generic equivalent of King Pharmaceutical's Altace capsules, indicated for the treatment of Pharmaceutical Business Review Roxane Laboratories, Inc. Announces the Launch of Ramipril Capsules - Jun 18, 2008 Roxane Laboratories' Ramipril Capsules are AB rated to ALTACE(R) (ramipril) Capsules. Annual sales of Ramipril Capsules, 1.25mg, 2.5mg, 5mg and 10mg are Earthtimes (press release), BUYINS.NET: (WYE) SqueezeTrigger Price is $44.287. There is ... - Jun 17, 2008 ...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release), King Pharmaceuticals Files Citizen Petition Relating to New Patent ... - May 27, 2008 Fundamental data is provided by Zacks Investment Research and market data is provided by AlphaTrade. All information provided "as is" for informational istockAnalyst.com, News Summary - 6/12 - Jun 11, 2008 2.5 mg, 5 mg and 10 mg doses, are the generic equivalent of Altace, a medicine manufactured by Tennessee-based King Pharmaceuticals Inc. for the treatment Daily Record (subscription), Brand Names/Synonyms: Altace is also known by the following brand names and/or synonymsAcovil; Altace; Carasel; Cardace; Delix; HOE 498; Hytren; Lostapres; Pramace; Quark; Ramace; Ramipril; Ramipril [Usan:Ban:Inn]; Ramiprilum [Latin]; Triatec; Tritace; Unipril; Vesdil Drug Category: Altace is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA05 Dosage Forms: CAPSULE Absorption: The extent of absorption is at least 50-60% and is not significantly influenced by the presence of food in the GI tract, although the rate of absorption is reduced. Interactions: Interactions for Ramipril: With nonsteroidal anti-inflammatory agents: Rarely, concomitant treatment with ACE inhibitors and nonsteroidal anti-inflammatory agents have been associated with worsening of renal failure and an increase in serum potassium. With Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ramipril. The possibility of hypotensive effects with ramipril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ramipril. If this is not possible, the starting dose should be reduced. With Potassium Supplements and Potassium-sparing Diuretics: Ramipril can attenuate potassium loss caused by thiazide diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored frequently. With Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. If a diuretic is also used, the risk of lithium toxicity may be increased. Other: Neither ramipril nor its metabolites have been found to interact with food, digoxin, antacid, furosemide, cimetidine, indomethacin, and simvastatin. The combination of ramipril and propranolol showed no adverse effects on dynamic parameters (blood pressure and heart rate). The co-administration of ramipril and warfarin did not adversely affect the anticoagulant effects of the latter drug. Additionally, co-administration of ramipril with phenprocoumon did not affect minimum phenprocoumon levels or interfere with the subjects' state of anti-coagulation. Chemical IUPAC Name: 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-4-azabicyclo[3.3.0]octane-3-carboxylicacid : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |